基因重组型人组织纤溶酶原激活剂溶栓治疗急性缺血性卒中

被引:10
作者
王少石
机构
[1] 上海交通大学附属第一人民医院分院神经内科
关键词
急性缺血性卒中; PA; 适应证; 人组织纤溶酶原激活剂; 时间窗; 溶栓治疗; 基因;
D O I
暂无
中图分类号
R743.3 [急性脑血管疾病(中风)];
学科分类号
摘要
引用
收藏
页码:961 / 962
页数:2
相关论文
共 7 条
[1]  
Randomised controlled trial of streptokinase,aspirin,and combination of both in treatment of acute ischaemic stroke. The Lancet . 1995
[2]  
Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric strokeThe European Cooperative Acute Stroke Study(ECASS). Hacke W,,Kaste M,Fieschi C,et al. The Journal of The American Medical Association . 1995
[3]  
Tissue activator for acute stroke. The New England Journal of Medicine . 1995
[4]  
Recommendations for the establishment of stroke systems of care:recommendations from the American Stroke Association‘s Task Force on the Development of Stroke Systems. Schwamm LH,Pancioli A,Acker JE. Stroke . 2005
[5]  
Guidelines for the early management of patients with ischemic stroke:2005guidelines update a scientific statement from the Stroke Council of the American Heart Association/American Stroke Association. Adams H,Adams R,Del Zoppo G,et al. Stroke . 2005
[6]  
Therapy of basilar artery occlusion:a systematic analysis comparing intra-arterial and intravenous thrombolysis. Lindsberg PJ,Mattle HP. Stroke . 2006
[7]  
Recombinant tissue plasminogen activator(rtPA)for strokeThe perspective at8years. Frey JL. Neurologist . 2005